|
1
|
Hiromatsu Y, Eguchi H, Tani J, Kasaoka M
and Teshima Y: Graves' ophthalmopathy: Epidemiology and natural
history. Intern Med. 53:353–360. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wang L and Ma JM: Progression of the
pathogenesis of thyroid associated ophthalmopathy. Zhonghua Yan Ke
Za Zhi. 53:474–480. 2017.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
3
|
Gu LQ, Jia HY, Zhao YJ, Liu N, Wang S, Cui
B and Ning G: Association studies of interleukin-8 gene in Graves'
disease and Graves' ophthalmopathy. Endocrine. 36:452–456.
2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Park M, Banga JP, Kim GJ, Kim M and Lew H:
Human placenta-derived mesenchymal stem cells ameliorate orbital
adipogenesis in female mice models of Graves' ophthalmopathy. Stem
Cell Res Ther. 10(246)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bahn RS and Heufelder AE: Retroocular
fibroblasts: Important effector cells in Graves' ophthalmopathy.
Thyroid. 2:89–94. 1992.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Weetman AP, Cohen S, Gatter KC, Fells P
and Shine B: Immunohistochemical analysis of the retrobulbar
tissues in Graves' ophthalmopathy. Clin Exp Immunol. 75:222–227.
1989.PubMed/NCBI
|
|
7
|
Khong JJ, McNab AA, Ebeling PR, Craig JE
and Selva D: Pathogenesis of thyroid eye disease: Review and update
on molecular mechanisms. Br J Ophthalmol. 100:142–150.
2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kumar S, Coenen M, Iyer S and Bahn RS:
Forkhead transcription factor FOXO1 is regulated by both a
stimulatory thyrotropin receptor antibody and insulin-like growth
factor-1 in orbital fibroblasts from patients with Graves'
ophthalmopathy. Thyroid. 25:1145–1150. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Underhill CB: The interaction of
hyaluronate with the cell surface: The hyaluronate receptor and the
core protein. Ciba Found Symp. 143:87–99; discussion 100-106,
281-285. 1989.PubMed/NCBI View Article : Google Scholar
|
|
10
|
van Steensel L, Paridaens D, Schrijver B,
Dingjan GM, van Daele PL, van Hagen PM, van den Bosch WA, Drexhage
HA, Hooijkaas H and Dik WA: Imatinib mesylate and AMN107 inhibit
PDGF-signaling in orbital fibroblasts: A potential treatment for
Graves' ophthalmopathy. Invest Ophthalmol Vis Sci. 50:3091–3098.
2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Jang SY, Park SJ, Chae MK, Lee JH, Lee EJ
and Yoon JS: Role of microRNA-146a in regulation of fibrosis in
orbital fibroblasts from patients with Graves' orbitopathy. Br J
Ophthalmol. 102:407–414. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wang Y and Smith TJ: Current concepts in
the molecular pathogenesis of thyroid-associated ophthalmopathy.
Invest Ophthalmol Vis Sci. 55:1735–1748. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li K, Du Y, Jiang BL and He JF: Increased
microRNA-155 and decreased microRNA-146a may promote ocular
inflammation and proliferation in Graves' ophthalmopathy. Med Sci
Monit. 20:639–643. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bhaskaran M and Mohan M: MicroRNAs:
History, biogenesis, and their evolving role in animal development
and disease. Vet Pathol. 51:759–774. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Bernardo BC, Ooi JYY, Lin RCY and McMullen
JR: miRNA therapeutics: A new class of drugs with potential
therapeutic applications in the heart. Future Med Chem.
7:1771–1792. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wu F, Zikusoka M, Trindade A, Dassopoulos
T, Harris ML, Bayless TM, Brant SR, Chakravarti S and Kwon JH:
MicroRNAs are differentially expressed in ulcerative colitis and
alter expression of macrophage inflammatory peptide-2α.
Gastroenterology. 135:1624–1635.e24. 2008.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Nakasa T, Miyaki S, Okubo A, Hashimoto M,
Nishida K, Ochi M and Asahara H: Expression of microRNA-146 in
rheumatoid arthritis synovial tissue. Arthritis Rheum.
58:1284–1292. 2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y,
Huang X, Zhou H, de Vries N, Tak PP, et al: MicroRNA-146A
contributes to abnormal activation of the type I interferon pathway
in human lupus by targeting the key signaling proteins. Arthritis
Rheum. 60:1065–1075. 2009.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Jang SY, Chae MK, Lee JH, Lee EJ and Yoon
JS: Role of miR-146a in the regulation of inflammation in an in
vitro model of Graves' orbitopathy. Invest Ophthalmol Vis Sci.
57:4027–4034. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wang N, Chen FE and Long ZW: Mechanism of
microrna-146a/notch2 signaling regulating il-6 in Graves
ophthalmopathy. Cell Physiol Biochem. 41:1285–1297. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Li H, Ma C, Liu W, He J and Li K:
Gypenosides protect orbital fibroblasts in Graves ophthalmopathy
via anti-inflammation and anti-fibrosis effects. Invest Ophthalmol
Vis Sci. 61(64)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Blandford Z, Zhang D, Chundury RV and
Perry JD: Dysthyroid optic neuropathy: Update on pathogenesis,
diagnosis, and management. Expert Rev Ophthalmol. 12:111–121.
2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yang IH, Rose GE, Ezra DG and Bailly M:
Macrophages promote a profibrotic phenotype in orbital fibroblasts
through increased hyaluronic acid production and cell
contractility. Sci Rep. 9(9622)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Iyer S and Bahn R: Immunopathogenesis of
Graves' ophthalmopathy: The role of the TSH receptor. Best Pract
Res Clin Endocrinol Metab. 26:281–289. 2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Longo CM and Higgins PJ: Molecular
biomarkers of Graves' ophthalmopathy. Exp Mol Pathol. 106:1–6.
2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Jang SY, Chae MK, Lee JH, Lee EJ and Yoon
JS: MicroRNA-27 inhibits adipogenic differentiation in orbital
fibroblasts from patients with Graves' orbitopathy. PLoS One.
14(e0221077)2019.PubMed/NCBI View Article : Google Scholar
|
